Acumen
Patient capital investing in social enterprises that deliver essential services to the poor
Our editorial assessment
Acumen represents a fundamentally different model of charity: rather than giving grants, they make equity and debt investments in social enterprises that serve low-income markets. When these investments succeed, the capital is recovered and reinvested — creating a self-sustaining cycle of impact. Over $140 million has been deployed into 150+ companies serving healthcare, clean energy, water, agriculture, and education across Africa and South Asia. The model is compelling but harder to evaluate than traditional charity: returns are measured in both social impact and financial sustainability, and the timeline is longer. Acumen is best suited for donors who are comfortable with a venture-capital-like approach to poverty reduction — higher risk per investment, but potentially transformative scale.
The problem they're solving
Traditional charity alone cannot solve poverty at the scale required. Acumen's thesis is that market-based solutions — companies that profitably serve the poor — can achieve sustainable impact that grants cannot. If correct, patient capital could unlock trillions of dollars of private investment for development.
About Acumen
Acumen uses "patient capital" — investing in social enterprises delivering healthcare, clean energy, and education to low-income communities.
Where your dollar goes
How this score was produced
The GiveWise score is our own editorial assessment, produced with a weighted rubric covering program spending, transparency and governance, evidence of impact, cost-effectiveness, and leadership. It draws on publicly available reports from independent evaluators such as GiveWell, Charity Navigator, and CharityWatch, but it is not a rating issued or endorsed by any of those organisations. Read the full methodology →